Other languages VolitionRx Limited

Equities

VNRX

US9286611077

Real-time Estimate Cboe BZX Other stock markets 10:24:49 2024-04-29 am EDT			5-day change	1st Jan Change
0.845 ^USD	-7.52%		+42.50%	+19.25%

Apr. 26	VolitionRx Limited Announces Board Changes	CI
Apr. 23	VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VolitionRx Limited Announces Board Changes	Apr. 26
VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech	Apr. 23
VolitionRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25
VolitionRx Limited Agrees Supply Agreement with Fujifilm Vet Systems Co. Ltd	Mar. 20
Volitionrx Limited Appoints Andrew Retter as Chief Medical Officer, Effective April 1, 2024	Mar. 19
Sector Update: Health Care Stocks Gain Late Afternoon	Jan. 02
Sector Update: Health Care	Jan. 02
VolitionRX Shares Soar After $13.0 Million Milestone Payments From Heska	Jan. 02
VolitionRx Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
VolitionRx Limited and Veterinary Pathology Group joins forces to launch the Nu.Q(R) Vet Cancer Test to veterinary practices in the UK and Ireland	Nov. 06
VolitionRx Limited Presents Breakthrough Liquid Biopsy Blood Test Method for Early-Stage Cancer	23-10-23
VolitionRx Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
VolitionRx Seeks Acquisitions	23-05-31
VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
VolitionRx Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-15
VolitionRx Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-15
VolitionRx Limited Auditor Raises 'Going Concern' Doubt	23-03-14
Sector Update: Health Care Stocks Gain in Afternoon Trading	23-02-17
Sector Update: Health Care	23-02-17
VolitionRX Prices $7.5 Million Public Offering of Common Stock	23-02-17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages VolitionRx Limited

Equities

VNRX

US9286611077

Other languages

Filters